We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
-11.25%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$7.17B
AUM Growth
-$1.2B
Cap. Flow
-$130M
Cap. Flow %
-1.82%
Top 10 Hldgs %
74.07%
Holding
91
New
10
Increased
15
Reduced
26
Closed
6

Top Buys

Rank Stock Value
1
SE icon
Sea Limited
SE
+$37.7M
2
EDU icon
New Oriental
EDU
+$15.7M
3
TAL icon
TAL Education Group
TAL
+$14.3M
4
EXAS
Exact Sciences
EXAS
+$12.6M
5
AXNX
Axonics, Inc. Common Stock
AXNX
+$8.03M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$31.3M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$18.9M
3
HD icon
Home Depot
HD
+$18.9M
4
AMZN icon
Amazon
AMZN
+$18.8M
5
MSFT icon
Microsoft
MSFT
+$18.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.17%
2 Financials 18.89%
3 Healthcare 13.64%
4 Consumer Staples 11.18%
5 Technology 9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISRG icon
26
Intuitive Surgical
ISRG
$127B
$20.8M 0.29%
125,811
– –
HUM icon
27
Humana
HUM
$43.6B
$20.4M 0.28%
65,000
+10,000
+18% +$3.37M
DXCM icon
28
DexCom
DXCM
$29.2B
$19.5M 0.27%
290,212
-122,336
-30% -$7.61M
EXAS
29
DELISTED
Exact Sciences
EXAS
$19.4M 0.27%
334,630
+155,698
+87% +$12.6M
WY icon
30
Weyerhaeuser
WY
$17.6B
$18.4M 0.26%
1,086,829
– –
EW icon
31
Edwards Lifesciences
EW
$49.3B
$18.1M 0.25%
287,241
– –
MRK icon
32
Merck
MRK
$326B
$17.4M 0.24%
237,611
– –
VRTX icon
33
Vertex Pharmaceuticals
VRTX
$125B
$16.3M 0.23%
68,557
– –
ILMN icon
34
Illumina
ILMN
$29.2B
$15.8M 0.22%
59,601
– –
TFX icon
35
Teleflex
TFX
$5.9B
$15.5M 0.22%
53,000
– –
CHRS icon
36
Coherus Oncology
CHRS
$219M
$14.7M 0.21%
908,464
+100,000
+12% +$1.85M
SRPT icon
37
Sarepta Therapeutics
SRPT
$1.63B
$14.2M 0.2%
145,329
– –
TAL icon
38
TAL Education Group
TAL
$6.05B
$14.1M 0.2%
+265,075
New +$14.3M
BMRN icon
39
BioMarin Pharmaceuticals
BMRN
$12B
$13.8M 0.19%
163,851
– –
LHCG
40
DELISTED
LHC Group LLC
LHCG
$13.4M 0.19%
95,657
– –
EDU icon
41
New Oriental
EDU
$9.11B
$13.2M 0.18%
+122,006
New +$15.7M
PODD icon
42
Insulet
PODD
$11.8B
$12.1M 0.17%
72,908
+15,000
+26% +$2.74M
NVCR icon
43
NovoCure
NVCR
$1.78B
$11.2M 0.16%
166,784
– –
BHVN
44
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$10.6M 0.15%
311,751
– –
TVRD
45
Tvardi Therapeutics
TVRD
$22.5M
$9.29M 0.13%
19,541
– –
HRTX icon
46
Heron Therapeutics
HRTX
$92.3M
$8.24M 0.12%
702,069
– –
GWPH
47
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$8.19M 0.11%
93,473
– –
AERI
48
DELISTED
Aerie Pharmaceuticals
AERI
$7.51M 0.1%
556,142
– –
INSM icon
49
Insmed
INSM
$22.5B
$7.1M 0.1%
443,110
– –
AXNX
50
DELISTED
Axonics, Inc. Common Stock
AXNX
$6.86M 0.1%
+270,000
New +$8.03M
1
2
3 4

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q1 2020 Portfolio in Review

As of Q1 2020, C WorldWide Group held 91 positions worth $7.17B, down 14% from $8.37B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

C WorldWide Group's Q1 2020 filing shows 10 new, 15 increased, 26 reduced and 6 closed positions. Its largest new stake was Sea Limited: 841,323 shares worth $37.3M. The largest sale was Visa, an estimated $31.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • C WorldWide Group's largest Q1 2020 buy was Sea Limited: 841,323 shares worth $37.3M.
  • C WorldWide Group added most to Exact Sciences in Q1 2020, an estimated $12.6M increase.
  • C WorldWide Group's biggest Q1 2020 reduction was Visa, cutting an estimated $31.3M.
  • C WorldWide Group fully exited Teladoc Health in Q1 2020, selling an estimated $16.3M.
  • C WorldWide Group's ten largest holdings make up 74% of its $7.17B portfolio in Q1 2020.
  • C WorldWide Group opened 10 new positions and closed 6 in Q1 2020.
  • C WorldWide Group's portfolio value fell 14% quarter-over-quarter to $7.17B.

Based on C WorldWide Group's 13F filing for Q1 2020, filed 4 May 2020.